FAQs

FAQs – Everything You Always Wanted to Know About No Deviation

At No deviation, we specialize in delivering tailored engineering, compliance, and validation solutions for the pharmaceutical and biotechnology industries. With over two decades of experience, our team has supported clients around the globe in building, qualifying, and operating GMP-compliant facilities.

This FAQ provides an overview of the types of projects we’ve successfully delivered, the current work we’re engaged in, the clients we serve, and the full range of services we offer. Whether you’re exploring our capabilities in Commissioning, Qualification & Validation (CQV), compliance consulting, or digital transformation, you’ll find answers to the most frequently asked questions about our methodologies, tools, and domain expertise.

Let’s talk and determine how we can support your pharmaceutical project from strategy to execution.

General Services / Company Overview

We have successfully delivered a wide range of pharmaceutical engineering projects, including:

  • Facility Design and Construction: Engineering and commissioning GMP-compliant manufacturing facilities, ensuring compliance with FDA, EMA, and PIC/S regulations.
  • Commissioning, Qualification, and Validation (CQV): Comprehensive services covering equipment, utilities, and systems, ensuring reliable operations from design qualification (DQ) to operational qualification (OQ).
  • Factory Acceptance Testing (FAT): Conducting rigorous pre-delivery inspections and readiness checks for equipment sourced globally, from Europe to Asia.
  • Digital Transformation: Implementation of digital platforms such as Kneat, improving data integrity, traceability, and remote verification capabilities.
  • Quality and Compliance Management: Setting up quality assurance systems that guarantee regulatory compliance, enhance operational efficiency, and reduce risks throughout the project lifecycle.

Our projects span across diverse geographical locations, including Europe, Asia, and the Americas, and are tailored specifically to each client’s unique requirements.

Cleaning Validation Project 

We provided comprehensive, end-to-end cleaning validation support, including: 

  • Equipment Cleanability Design Review: 
    Conducted initial Installation Qualification (IQ) and Operational Qualification (OQ), including coverage and drainability tests. 
  • Flow Path and Strategy Definition: 
    Identified product and cleaning flow paths, defined optimal cleaning strategies, and established worst-case scenarios. 
  • Protocol Development and Integration: 
    Drafted detailed validation protocols, planned, and integrated cleaning tests with engineering runs. 
  • Result Collection and Equipment Release: 
    Collected validation data, investigated discrepancies, and released equipment for GMP manufacturing. 
  • Routine Monitoring and Continuous Verification: 
    Implemented ongoing cleaning verification programs, including bioburden monitoring and evaluation aligned with Annex 1 requirements. 
  • Our dedicated cleaning and process SMEs ensured compliance with FDA, EMA, and PIC/S regulatory requirements for aseptic biological product manufacturing, emphasizing quality, safety, and continuous improvement. 
Commissioning Strategy and Support 

Leveraging over 20 years of industry experience, we support clients from early project initiation through final GMP release. Our extensive database and expertise enable accurate estimation of Commissioning & Qualification (C&Q) efforts based on project scope, effectively identifying team capabilities, market maturity, risks, and opportunities to optimize your CQ bidding process. 

Our experienced team applies a risk-based and science-based approach to: 

  • Strategy Development: 
    • Define execution strategies aligned with available resources and regulatory requirements.  
  • Execution and Management: 
    • Conduct comprehensive commissioning and qualification activities covering: 
      • Black utilities, HVAC utilities, and critical process equipment. 
      • Vendor assessments and audits. 
      • Construction verification and design reviews (Design Qualification – DQ).
      • Mechanical completion activities.
      • FAT (Factory Acceptance Testing) and SAT (Site Acceptance Testing). 
      • Drafting and executing Installation Qualification (IQ) and Operational Qualification (OQ) protocols. 
  • Automation and Data Integrity: 
    • Integrate automation solutions and data integrity considerations throughout commissioning and qualification activities. 
  • Project Controls: 
    • Manage change control, nonconformities, and punch-list resolution. 
  • Documentation and GMP Release: 
    • Deliver final Qualification Summary Reports. Facilitate equipment acceptance and release for GMP manufacturing. 

Our integrated approach ensures compliance, efficiency, and robust qualification aligned with FDA, EMA, and PIC/S guidelines. 

  • We have served a diverse range of clients across the pharmaceutical and biotechnology sectors, including: 
  • Global Pharmaceutical Manufacturers: Large-scale facilities requiring comprehensive GMP compliance and commissioning support. 
  • Biotechnology Companies: Firms focused on aseptic biological products, advanced therapies, and vaccine production. 
  • Contract Manufacturing Organizations (CMOs/CDMOs): Companies needing flexible, regulatory-compliant facility setups and validation. 
  • Engineering, Procurement & Construction Management (EPCM) Firms: Partners requiring specialized commissioning and qualification expertise integrated into large-scale projects. 
  • Startups and Innovative Biotechs: Early-stage companies requiring strategic planning, validation, and regulatory guidance to efficiently bring new products to market. 
  • Our experience spans regulated markets in North America, Europe, and Asia, ensuring tailored solutions aligned with FDA, EMA, and PIC/S regulatory requirements. 
CQV Services
  • Strategy Definition 
  • Contamination Control Strategy (CCS) Definition and Assessment 
  • Protocol Drafting and Execution: 
    (SIA, URS, DR, DQ, FAT, SAT, IQ, OQ, PQ, CAV, CSA, CV, PV) 
  • Digitalization of CQV Activities 
  • Project Management 
Compliance and Quality Services
  • Training 
  • Supplier Audits 
  • Pharmaceutical Quality System (PQS) Definition and Implementation 
  • GMP Readiness 
  • GMP Remediation 
  • CAPA Investigation and Implementation 
  • Mock Audits 
Want to discuss your project with us?

If you’re interested in how our experience can benefit your project, let’s schedule a discovery call.
Contact us at hello@nodeviation.com to learn how we can support your next project.

Commissioning, Qualification and Validation Services (CQV)

We follow a structured, risk-based CQV methodology developed over more than 20 years of experience with diverse critical projects. As active contributors to industry-leading organizations such as ASTM E2500 and ISPE, and early adopters of ICH Q9, risk management is central to our process. This approach helps us prioritize critical systems and processes based on their potential impact on product quality and patient safety, optimizing resources and efficiency. Understanding the organizational challenges inherent in risk-based CQV, we ensure your project is managed effectively to deliver maximum value.

Our team has extensive experience navigating global regulatory compliance requirements. We regularly interact with regulatory authorities including the FDA, EMA, and PIC/S through client consultations, organizational memberships, and active participation in industry communities of practice, such as ISPE’s CQV and Drug Shortage CoPs. Our proactive involvement includes contributing to industry guidance documents, participating in reviews, workshops, and authoring publications. This continuous engagement ensures that our CQV processes, documentation, and execution consistently meet current Good Manufacturing Practice (cGMP) standards and remain inspection-ready. 

Our commitment to data integrity is supported by three fundamental pillars: robust systems, clear and comprehensive procedures, and an ingrained integrity-focused mindset. Our engineering team thoroughly understands the importance of data integrity at every stage of our operations. Leveraging our ISO 9001 certification and advanced electronic documentation platforms such as Kneat, we maintain complete traceability, reliable data management, and comprehensive compliance throughout the entire CQV lifecycle. 

Yes, we offer specialized validation services, including extensive expertise in thermal mapping studies, computerized systems validation (CSV), cleaning validation, and many other areas. Our highly skilled professionals combine hands-on project experience with strong auditing capabilities, ensuring thorough validations aligned with regulatory standards and industry best practices. From strategy development to execution, we can also support your organization in identifying and managing qualified local partners, preparing bid documentation, and performing technical evaluations. 

Want to challenge your CSV strategy?

Ready to optimize your CQV strategy? Let’s align on your current challenges and how we can support.
Contact us at hello@nodeviation.com to learn how we can support your next project.

Kneat Services

We provide comprehensive Kneat support, from initial setup and configuration to the development of customized test protocols and workflows tailored specifically to your project requirements. Additionally, we offer platform governance and ongoing management services, allowing you to focus on your core project tasks with greater efficiency and quality. As Kneat’s oldest partner, we have extensive experience with multiple-instance deployments and have accumulated valuable practical knowledge through our active Community of Practice. This ensures that your onboarding experience is smooth, accelerating your path to project execution and maximizing your return on investment. Whether you require Kneat stewardship, test case library generation, or complete platform management, we ensure your projects run faster and more effectively. 

Want to discover Kneat?

Want to get the most out of your Kneat platform? Let’s discuss how we can streamline your digital validation.
Contact us at hello@nodeviation.com to learn how we can support your next project.

CSV, CSA, and Accelerated Project Delivery

The primary pitfall of CSV is “testing for the sake of testing,” where the focus shifts from ensuring the system truly meets its intended purpose to simply generating paperwork for auditors. This often leads to a situation where a system is deemed compliant because protocols are followed and documents are filled out, but it doesn’t necessarily guarantee that the system effectively achieves the desired business outcomes or provides real value. The emphasis is on demonstrating what the system can do through individual tests, rather than demonstrating that the system does the right thing for its intended use.

Consider a system that mixes two chemicals in a specific ratio, maintaining a certain temperature and stirring. Traditional CSV might involve individually testing the flow meters, temperature controls, and stirrer to ensure they function as specified (e.g., valve opens to 50%, flow meter reads correctly). However, it might not directly test the “intended outcome,” which is the quality and consistency of the final chemical mixture produced at the end of the process. The individual components might pass their tests, but if the valve type is incorrect (e.g., equal opening instead of linear), the intended ratio and thus the final product quality could still be wrong. Traditional CSV often tests individual equipment performance in isolation, rather than the integrated process outcome.

CSA shifts the focus from exhaustive documentation and testing of every individual component to a risk-based approach that prioritises critical aspects of the system directly impacting product quality and patient safety. Instead of testing for the sake of testing, CSA emphasises demonstrating that the system consistently achieves its intended outcomes. This involves a deeper understanding of the process and integrating testing earlier in the lifecycle, focusing on proving the end result first. The assumption is that if the desired outcome is consistently achieved, the underlying components must be functioning correctly implicitly, with less emphasis on lengthy, isolated component testing.

By focusing on intended outcomes and integrating testing earlier, CSA can significantly reduce wasted effort and rework. Traditional waterfall approaches with sequential reviews and sign-offs often lead to delays and the need for re-explanation when issues are found late in the project. CSA encourages cross-functional teams (automation, process, operations, and potentially quality) to collaborate from the initial design phase, collectively defining requirements and how the system will achieve its purpose. This early alignment and continuous informal design reviews (which are essentially testing) reduce misunderstandings and ensure everyone is on the same page, leading to faster design, development, and testing cycles. Breaking down work into smaller, testable units (like in agile “sprints”) allows for quicker feedback and earlier identification of problems, preventing large batches of code or configurations needing rework at the end.

An informal design review in this context is essentially continuous testing and verification conducted by the integrated project team throughout the development process. It’s a highly structured yet less formal than traditional validation phases, focusing on demonstrating that small, functional units of the system (often software code) achieve their intended purpose. These reviews involve explicit test steps, recording observations (similar to a lab notebook), and documenting any issues encountered and their resolutions. The goal is to iteratively build and verify the system in smaller increments, banking progress as each unit is successfully tested, rather than waiting for a large, formal validation phase at the end.

Early and continuous collaboration ensures that the automation design is driven by the actual process needs and operational requirements. This prevents situations where automation is designed in isolation and then found to be unsuitable or inefficient for the intended use. With everyone involved from the start, there’s a shared understanding of the system’s purpose and limitations, leading to a “fit for purpose” design. This reduces the likelihood of significant rework later in the project due to misunderstandings or overlooked requirements. Quality is improved by design, not just by testing at the end.

With a modular and iteratively tested system under CSA, late changes can be addressed more efficiently. Because the system is broken down into smaller, independently tested units, a change in one area is less likely to have a cascading effect on the entire validation package. Instead of having to rewrite and re-execute extensive FAT protocols and manage numerous change controls on a locked-down system, changes can be implemented by modifying the relevant code or configuration, re-testing that specific unit through the informal design review process, and ensuring the database reflects the updated and tested state. This allows for greater flexibility and faster adaptation to evolving needs without causing major project delays.

  • Safety: Safety is inherently addressed through the focus on intended outcomes and critical aspects impacting the product. Early involvement of EHS considerations within the integrated team ensures safety requirements are embedded in the design.
  • Quality: Higher quality outcomes are achieved through a “fit for purpose” system designed collaboratively with a focus on the actual process needs. Quality is built into the process through continuous testing and verification, leading to fewer failures in later formal testing. There is also less duplication of effort and a more aligned understanding of the system’s purpose.
  • Delivery: Project delivery is accelerated by reducing waiting times between teams, enabling parallel work on smaller units, and minimising rework due to early issue detection and resolution. The iterative approach and continuous informal design reviews streamline the development and testing cycles.
  • Cost: Cost savings are realised through reduced rework, less idle time for team members, and a more efficient overall project lifecycle. By focusing on value-added activities and minimising unnecessary documentation and testing, resources are used more effectively.
Want to put CSA into practice?

At No deviation, we’ve successfully delivered projects using this CSA-driven approach, helping clients accelerate delivery while improving quality and compliance.
Contact us at hello@nodeviation.com to learn how we can support your next automation or validation project.